Literature DB >> 10891910

Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy).

P Kelkar1, M Masood, G J Parry.   

Abstract

OBJECTIVE: To investigate the pathogenesis of proximal diabetic neuropathy (PDN) with nerve and muscle biopsies.
BACKGROUND: Recent evidence suggests that nerve ischemia secondary to immune-mediated vasculopathy rather than diabetic microangiopathy may be responsible for PDN.
METHOD: - Fifteen patients with PDN and two diabetic controls underwent nerve and muscle biopsy and clinical, electrophysiologic, and laboratory evaluation. There were eight men and seven women between 49 and 79 years of age with type II diabetes. All had progressive, painful, asymmetric, proximal weakness with duration of 5 weeks to 12 months. None had evidence of systemic autoimmune disorder.
RESULTS: Four patients showed the distinctive findings of polymorphonuclear small-vessel vasculitis affecting epineurial vessels with transmural infiltration of postcapillary venules with polymorphonuclear leukocytes. Immunoglobulin M (IgM) deposits were found along the endothelium and intramurally in affected vessels. IgM staining was seen in the subperineurial space and in the endoneurium. Activated complement deposition was seen along endothelium of small vessels. Three of these four patients were evaluated within 6 seeks of onset of PDN, and the fourth patient during acute flare of PDN 6 months after the initial onset. Six patients showed "perivasculitis" with mononuclear cell infiltrates around small epineurial vessels without vasculitis (fibrinoid necrosis or transmural inflammation). One patient showed recanalized vessels with transmural lymphocytes without fibrinoid necrosis, possibly suggesting healed vasculitis.
CONCLUSION: These distinctive pathologic findings support that proximal diabetic neuropathy has an immune-mediated inflammatory basis and suggest that polymorphonuclear vasculitis with immune complex and complement deposition may be the primary event in the acute phase of proximal diabetic neuropathy.

Entities:  

Mesh:

Year:  2000        PMID: 10891910     DOI: 10.1212/wnl.55.1.83

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Global respiratory insufficiency due to proximal diabetic neuropathy.

Authors:  Dietrich Haubenberger; Walter Rinner; Eduard Auff; Elisabeth Fertl
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

Review 2.  Focal and multifocal neuropathies.

Authors:  Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 3.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

4.  Intravenous immunoglobulin therapy in proximal diabetic neuropathy.

Authors:  Yuichi Kawagashira; Hirohisa Watanabe; Yumiko Oki; Masahiro Iijima; Haruki Koike; Naoki Hattori; Masahisa Katsuno; Fumiaki Tanaka; Gen Sobue
Journal:  BMJ Case Rep       Date:  2009-01-23

5.  Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy?

Authors:  Mercedes Garces-Sanchez; Ruple S Laughlin; Peter J Dyck; JaNean K Engelstad; Jane E Norell; P James B Dyck
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

6.  Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy.

Authors:  Pariwat Thaisetthawatkul; P James B Dyck
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

Review 7.  Immunotherapy for diabetic amyotrophy.

Authors:  Yee Cheun Chan; Yew Long Lo; Edwin Sy Chan
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

Review 8.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

Review 9.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

10.  Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy.

Authors:  Y Kawagashira; H Watanabe; Y Oki; M Iijima; H Koike; N Hattori; M Katsuno; F Tanaka; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.